Hermann Richard C, Yang Dawei, Ettner Susan L, Marcus Steven C, Yoon Cathy, Abraham Melissa
Department of Psychiatry, Cambridge Hospital, Cambridge, Massachusetts 02139, USA.
Psychiatr Serv. 2002 Apr;53(4):425-30. doi: 10.1176/appi.ps.53.4.425.
This study examined trends in the prescription of antipsychotic drugs in a nationally representative sample of physicians in nonfederal office-based clinical practice during the 1990s.
The authors analyzed physician-reported data from annual National Ambulatory Medical Care Surveys between 1989 and 1997 using weighted national estimates of physician visits during which antipsychotic drugs were prescribed. Prescription rates for antipsychotic drugs were compared between periods and among demographic, organizational, and clinical subgroups.
Prescription of antipsychotic drugs in office-based practice increased significantly between 1989 and 1997. In 1989 antipsychotics were prescribed during 3.2 million office visits (.46 percent of all visits), compared with 6.9 million visits in 1997 (.88 percent). The atypical antipsychotics risperidone and olanzapine were the most widely prescribed antipsychotics in 1997. Risperidone was prescribed during 22.8 percent of all visits that involved prescription of an antipsychotic, and olanzapine during 17.1 percent. Psychiatrists were more likely than other physicians to prescribe an atypical agent (37.1 percent of visits involving prescription of an antipsychotic compared with 14.2 percent). Psychiatrists were also more likely than other physicians to schedule a follow-up visit after prescribing an antipsychotic (96.6 percent of visits compared with 73 percent). No evidence was found of a broadening of diagnostic indications for use over time.
The rate of prescription of antipsychotic drugs among office-based physicians increased sharply during the 1990s after a nine-year decline. The increase was accounted for by growth in the use of atypical antipsychotics; the overall prescription rate of conventional agents did not change. Psychiatrists were more likely to prescribe atypical agents and to monitor more closely patients who were taking antipsychotics.
本研究调查了20世纪90年代在全国具有代表性的非联邦门诊临床执业医师样本中抗精神病药物的处方趋势。
作者分析了1989年至1997年年度全国门诊医疗调查中医生报告的数据,使用了开具抗精神病药物的门诊就诊次数的加权全国估计数。比较了不同时期以及人口统计学、机构和临床亚组之间抗精神病药物的处方率。
1989年至1997年期间,门诊执业中抗精神病药物的处方量显著增加。1989年,在320万次门诊就诊中开具了抗精神病药物(占所有就诊次数的0.46%),而1997年为690万次就诊(占0.88%)。非典型抗精神病药物利培酮和奥氮平是1997年处方最广泛的抗精神病药物。在所有开具抗精神病药物的就诊中,22.8%的就诊开具了利培酮,17.1%的就诊开具了奥氮平。精神科医生比其他医生更有可能开具非典型药物(开具抗精神病药物的就诊中,精神科医生占37.1%,其他医生占14.2%)。精神科医生在开具抗精神病药物后安排随访就诊的可能性也比其他医生更高(分别为96.6%和73%)。未发现随着时间推移诊断适应症有所拓宽的证据。
在经历了九年的下降之后,20世纪90年代门诊医生中抗精神病药物的处方率急剧上升。这种增加是由于非典型抗精神病药物使用的增长;传统药物的总体处方率没有变化。精神科医生更有可能开具非典型药物,并对服用抗精神病药物的患者进行更密切的监测。